Cargando…
Osteoglycin as a Potential Biomarker of Mild Kidney Function Impairment in Type 2 Diabetes Patients
Osteoglycin (OGN) could be a biomarker of mild kidney function impairment in type 2 diabetes (T2D). Our study aimed to determine the association between serum OGN and impaired kidney function risk in T2D patients and to analyze its potential role as an estimator of kidney disturbances in this popula...
Autores principales: | González-Salvatierra, Sheila, García-Fontana, Cristina, Andújar-Vera, Francisco, Grau-Perales, Alejandro Borja, Martínez-Heredia, Luis, Avilés-Pérez, María Dolores, Hayón-Ponce, María, Iglesias-Baena, Iván, Riquelme-Gallego, Blanca, Muñoz-Torres, Manuel, García-Fontana, Beatriz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161135/ https://www.ncbi.nlm.nih.gov/pubmed/34065223 http://dx.doi.org/10.3390/jcm10102209 |
Ejemplares similares
-
Exploring the Role of Sclerostin as a Biomarker of Cardiovascular Disease and Mortality: A Scoping Review
por: Sanabria-de la Torre, Raquel, et al.
Publicado: (2022) -
Analysis of the Genetic Relationship between Atherosclerosis and Non-Alcoholic Fatty Liver Disease through Biological Interaction Networks
por: Andújar-Vera, Francisco, et al.
Publicado: (2023) -
Undercarboxylated Osteocalcin: A Promising Target for Early Diagnosis of Cardiovascular and Glycemic Disorders in Patients with Metabolic Syndrome: A Pilot Study
por: Riquelme-Gallego, Blanca, et al.
Publicado: (2022) -
Identification of Potential Targets Linked to the Cardiovascular/Alzheimer’s Axis through Bioinformatics Approaches
por: Andújar-Vera, Francisco, et al.
Publicado: (2022) -
Circulating Undercarboxylated Osteocalcin as Estimator of Cardiovascular and Type 2 Diabetes Risk in Metabolic Syndrome Patients
por: Riquelme-Gallego, Blanca, et al.
Publicado: (2020)